These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18941234)

  • 21. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of Unique Hepatitis C Virus-Specific Public CD8
    Mazouz S; Boisvert M; Abdel-Hakeem MS; Khedr O; Bruneau J; Shoukry NH
    J Immunol; 2021 Aug; 207(4):1180-1193. PubMed ID: 34341170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man.
    Bowen DG; Walker CM
    J Exp Med; 2005 Jun; 201(11):1709-14. PubMed ID: 15939787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
    Vali B; Tohn R; Cohen MJ; Sakhdari A; Sheth PM; Yue FY; Wong D; Kovacs C; Kaul R; Ostrowski MA
    J Virol; 2011 Jan; 85(1):254-63. PubMed ID: 20980521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
    J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site.
    Neumann-Haefelin C; Killinger T; Timm J; Southwood S; McKinney D; Blum HE; Thimme R
    J Gen Virol; 2007 Jul; 88(Pt 7):1986-1991. PubMed ID: 17554032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Neumann-Haefelin C; Timm J; Spangenberg HC; Wischniowski N; Nazarova N; Kersting N; Roggendorf M; Allen TM; Blum HE; Thimme R
    Hepatology; 2008 Jun; 47(6):1824-36. PubMed ID: 18454507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness.
    Uebelhoer L; Han JH; Callendret B; Mateu G; Shoukry NH; Hanson HL; Rice CM; Walker CM; Grakoui A
    PLoS Pathog; 2008 Sep; 4(9):e1000143. PubMed ID: 18773115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.
    Spear TT; Riley TP; Lyons GE; Callender GG; Roszkowski JJ; Wang Y; Simms PE; Scurti GM; Foley KC; Murray DC; Hellman LM; McMahan RH; Iwashima M; Garrett-Mayer E; Rosen HR; Baker BM; Nishimura MI
    J Leukoc Biol; 2016 Sep; 100(3):545-57. PubMed ID: 26921345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and biological basis of CTL escape in coronavirus-infected mice.
    Butler NS; Theodossis A; Webb AI; Dunstone MA; Nastovska R; Ramarathinam SH; Rossjohn J; Purcell AW; Perlman S
    J Immunol; 2008 Mar; 180(6):3926-37. PubMed ID: 18322201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memory generation and maintenance of CD8+ T cell function during viral persistence.
    Cush SS; Anderson KM; Ravneberg DH; Weslow-Schmidt JL; Flaño E
    J Immunol; 2007 Jul; 179(1):141-53. PubMed ID: 17579032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections.
    Shoukry NH; Sidney J; Sette A; Walker CM
    J Immunol; 2004 Jan; 172(1):483-92. PubMed ID: 14688358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral sequence evolution in acute hepatitis C virus infection.
    Kuntzen T; Timm J; Berical A; Lewis-Ximenez LL; Jones A; Nolan B; Schulze zur Wiesch J; Li B; Schneidewind A; Kim AY; Chung RT; Lauer GM; Allen TM
    J Virol; 2007 Nov; 81(21):11658-68. PubMed ID: 17699568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
    Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.